Eisai eyes fiscal 2025 U.S. approval for home version of Alzheimer’s drug 2025-01-22T18:04:06-05:00January 22nd, 2025| share this article![#item_full_content] Read More share this article! Related Posts China vows to protect overseas interests as hurdles and uncertainties mount January 22nd, 2025 Indian water purifier firm Kent R O files draft papers for IPO January 22nd, 2025 Malaysia’s Sunway Healthcare hires banks for $675m IPO: report January 22nd, 2025 Saudi prince’s Kingdom Holding will be keen on TikTok if Musk or others buy it January 22nd, 2025
